Catalyst Wire Dossier Catalyst Wire Dossier

Glycopyrrolate inhalation solution

glycopyrrolate · Verona Pharma plc
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Glycopyrrolate inhalation solution, covering 2021-04-08 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIb Study of Glycopyrrolate Inhalation Solution Over 1 Week in Subjects With COPD [Phase 2]

See pricing